REFRACTORY/RELAPSED ACUTE MYELOID LEUKAEMIA

Clinical trials for REFRACTORY/RELAPSED ACUTE MYELOID LEUKAEMIA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY/RELAPSED ACUTE MYELOID LEUKAEMIA trials appear

Sign up with your email to follow new studies for REFRACTORY/RELAPSED ACUTE MYELOID LEUKAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Scientists test re-engineered immune cells as a new weapon against tough leukemia

Disease control Recruiting now

This early-stage trial is testing the safety and finding the right dose of a new type of CAR-T cell therapy called FL-33 for people with acute myeloid leukemia that has come back or hasn't responded to other treatments. The study will enroll up to 27 adults and children to see ho…

Matched conditions: REFRACTORY/RELAPSED ACUTE MYELOID LEUKAEMIA

Phase: PHASE1 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

REFRACTORY/RELAPSED ACUTE MYELOID LEUKAEMIA

Get alerted when new REFRACTORY/RELAPSED ACUTE MYELOID LEUKAEMIA trials appear

Scientists test re-engineered immune cells as a new weapon against tough leukemia